55,000
Participants
Start Date
August 21, 2023
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
no intervention
not applicable, this is an observational retrospective data analysis study; no interventions in the study
COMPLETED
Research Site, Eden Prairie
RECRUITING
Research Site, Calgary
COMPLETED
Research Site, Beijing
COMPLETED
Research Site, Changsha
COMPLETED
Research Site, Chengdu
COMPLETED
Research Site, Guangzhou
COMPLETED
Research Site, Wuhan
RECRUITING
Research Site, Horsens
RECRUITING
Research Site, Berlin
COMPLETED
Research Site, Tokyo
NOT_YET_RECRUITING
Research Site, Lisbon
NOT_YET_RECRUITING
Research Site, Porto
COMPLETED
Research Site, A Coruña
COMPLETED
Research Site, Barcelona
COMPLETED
Research Site, Bilbao
COMPLETED
Research Site, El Palmar
COMPLETED
Research Site, Huelva
COMPLETED
Research Site, Las Palmas de Gran Canaria
COMPLETED
Research Site, Madrid
COMPLETED
Research Site, Majadahonda
COMPLETED
Research Site, Palma de Mallorca
COMPLETED
Research Site, Salamanca
COMPLETED
Research Site, Valencia
COMPLETED
Research Site, Södertälje
RECRUITING
Research Site, Umeå
COMPLETED
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY